Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 135


Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study.

Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, Fisher RA, Merion RM.

Am J Transplant. 2016 Feb;16(2):594-602. doi: 10.1111/ajt.13479. Epub 2015 Oct 13.


The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications.

Hecht E, Freise C, Websky KV, Nasser H, Kretzschmar N, Stawowy P, Hocher B, Querfeld U.

Nephrol Dial Transplant. 2015 Sep 1. pii: gfv321. [Epub ahead of print]


Defining long-term outcomes with living donor liver transplantation in North America.

Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR Jr, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.

Ann Surg. 2015 Sep;262(3):465-75; discussion 473-5. doi: 10.1097/SLA.0000000000001383.


Laparoscopic Nephrectomy with Autotransplantation: Safety, Efficacy and Long-Term Durability.

Tran G, Ramaswamy K, Chi T, Meng M, Freise C, Stoller ML.

J Urol. 2015 Sep;194(3):738-43. doi: 10.1016/j.juro.2015.03.089. Epub 2015 Mar 20.


The lignan (+)-episesamin interferes with TNF-α-induced activation of VSMC via diminished activation of NF-ĸB, ERK1/2 and AKT and decreased activity of gelatinases.

Freise C, Querfeld U.

Acta Physiol (Oxf). 2015 Mar;213(3):642-52. doi: 10.1111/apha.12400. Epub 2014 Oct 13.


K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.

Freise C, Heldwein S, Erben U, Hoyer J, Köhler R, Jöhrens K, Patsenker E, Ruehl M, Seehofer D, Stickel F, Somasundaram R.

Liver Int. 2015 Apr;35(4):1244-52. doi: 10.1111/liv.12681. Epub 2014 Sep 22.


Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).

Ladner DP, Dew MA, Forney S, Gillespie BW, Brown RS Jr, Merion RM, Freise CE, Hayashi PH, Hong JC, Ashworth A, Berg CL, Burton JR Jr, Shaked A, Butt Z.

J Hepatol. 2015 Feb;62(2):346-53. doi: 10.1016/j.jhep.2014.08.043. Epub 2014 Sep 6.


Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study.

Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, Freise CE, Gillespie BW, Everhart JE.

Liver Transpl. 2015 Jan;21(1):79-88. doi: 10.1002/lt.23966. Epub 2014 Oct 6.


Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.

Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA.

Liver Transpl. 2014 Oct;20(10):1202-10. doi: 10.1002/lt.23937. Epub 2014 Sep 3.


Emesis following laparoscopic left donor nephrectomy.

Luu HY, Ulloa JG, Roll GR, Freise CE.

Am J Transplant. 2014 Jul;14(7):1701; quiz 1700, 1702. doi: 10.1111/ajt.12685. No abstract available.


Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.

Freise C, Querfeld U.

Pharmacol Res. 2014 Jul;85:6-14. doi: 10.1016/j.phrs.2014.04.013. Epub 2014 May 6.


Wideband MRE and static mechanical indentation of human liver specimen: sensitivity of viscoelastic constants to the alteration of tissue structure in hepatic fibrosis.

Reiter R, Freise C, Jöhrens K, Kamphues C, Seehofer D, Stockmann M, Somasundaram R, Asbach P, Braun J, Samani A, Sack I.

J Biomech. 2014 May 7;47(7):1665-74. doi: 10.1016/j.jbiomech.2014.02.034. Epub 2014 Mar 5.


Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.

Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown RS Jr, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond JC, Stiles JB, Lukose T, Chang MS, Klintmalm G.

Clin Transplant. 2013 Nov-Dec;27(6):829-37. doi: 10.1111/ctr.12224. Epub 2013 Sep 3.


Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.

Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G.

Liver Transpl. 2013 Sep;19(9):1020-9. doi: 10.1002/lt.23703.


Ex vivo split-liver transplantation: the true right/left split.

Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE.

HPB (Oxford). 2014 Mar;16(3):267-74. doi: 10.1111/hpb.12113. Epub 2013 Apr 22.


Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.

Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM.

Liver Transpl. 2013 Mar;19(3):259-67. doi: 10.1002/lt.23595.


Fever and rash one month after orthotopic liver transplantation.

Hobeika M, Pollitt R, Freise C, Shinkai K.

Am J Transplant. 2013 Jan;13(1):236-8; quiz 238. doi: 10.1111/j.1600-6143.2012.04309.x. No abstract available.


The inhibitor of Ca(2+)-dependent K+ channels TRAM-34 blocks growth of hepatocellular carcinoma cells via downregulation of estrogen receptor alpha mRNA and nuclear factor-kappaB.

Freise C, Ruehl M, Seehofer D, Hoyer J, Somasundaram R.

Invest New Drugs. 2013 Apr;31(2):452-7. doi: 10.1007/s10637-012-9879-6. Epub 2012 Oct 2.


Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.

Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS; A2ALL Study Group.

Am J Transplant. 2012 Nov;12(11):2997-3007. doi: 10.1111/j.1600-6143.2012.04272.x. Epub 2012 Sep 20.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk